CONDITION
Injection-Site Sarcoma in Cats
An injection-site sarcoma is a type of tumour that can develop in cats at locations where injections have been given in the past. These growths arise from the soft tissue beneath the skin and tend to grow locally, often with irregular borders that make complete removal challenging. The link between certain vaccines or injectable medications and these tumours was recognised in the 1990s, though they remain uncommon overall. Owners typically notice a firm lump or swelling under the skin, often between the shoulder blades, along the back, or in the hind leg—areas where vaccines and other injections are commonly given. The lump may appear weeks, months, or even years after an injection. Not every lump at an injection site is a sarcoma; many are benign reactions that resolve on their own, but lumps that persist, grow, or appear after the expected healing window tend to prompt further investigation. This page explores what changes may signal concern, what is understood about how these tumours develop, how they are investigated through imaging and biopsy, and the range of approaches available—including surgery, radiation, and chemotherapy—each with its own scope and tradeoffs.
Why this matters now
Injection-site sarcomas tend to develop in adult and older cats, most often appearing between the ages of eight and twelve years, though younger cats can occasionally be affected. The time lag between injection and tumour detection varies considerably; some masses are noticed within a few months, whilst others may not become apparent for several years. There is no strong breed predisposition, and both neutered and intact cats appear equally susceptible. The key trigger is thought to be the local tissue inflammation that follows certain injections, particularly adjuvanted vaccines or long-acting injectable medications.
These tumours often grow slowly at first, which can make early lumps easy to overlook or attribute to a simple reaction. Once established, however, they tend to enlarge steadily over weeks to months, and their growth pattern is characteristically invasive—extending along tissue planes and sending microscopic projections beyond the palpable mass. Because of this infiltrative behaviour, complete surgical removal can be difficult, and recurrence at the same site is not uncommon even after initial treatment. The biological behaviour varies between individuals; some tumours remain localised for extended periods, whilst others grow more aggressively or, in a small proportion of cases, spread to distant sites such as the lungs or lymph nodes.
Signals & patterns
Early signals
Firm lump under the skin
The owner may notice a small, firm swelling at a site where the cat has previously received an injection—commonly between the shoulder blades, along the flank, or on a hind leg. The lump often feels distinct from the surrounding tissue and does not seem painful when touched.
Lump persisting beyond healing time
A raised area or swelling that remains unchanged or continues to be palpable more than three months after an injection may warrant attention, as benign post-injection reactions typically resolve within a few weeks. Persistence alone does not confirm a sarcoma, but it marks a shift in the expected timeline.
Gradual increase in size
An initially small lump that grows steadily over the course of weeks or months, rather than shrinking or stabilising, can signal a process beyond normal healing. The rate of growth varies, and some masses enlarge very slowly in the early stages.
Lump becoming more obvious
As the mass grows, it may become easier to see as well as feel, creating a visible bulge beneath the fur or causing asymmetry in the body contour. This change often prompts closer observation by the owner.
Later signals
Rapid enlargement of the mass
A lump that has been stable or slow-growing may begin to increase in size more quickly, doubling over the course of weeks rather than months. This shift in tempo can reflect progression within the tumour itself.
Attachment to underlying tissue
The mass may feel less mobile and more firmly anchored to deeper structures such as muscle or fascia, making it difficult to shift beneath the skin. This reflects the tumour's tendency to infiltrate surrounding tissue planes.
Ulceration or skin changes
In some cases, the overlying skin may become stretched, thinned, or broken, leading to visible sores or discharge. This typically occurs when a tumour has grown large enough to compromise the integrity of the skin above it.
Discomfort or lameness
If the mass is located near a limb or involves muscle or nerve tissue, the cat may begin to show reluctance to move, stiffness, or favouring of the affected leg. Pain is not always present but may develop as the tumour expands or invades sensitive structures.
Click to read about the biological mechanisms
How this is usually investigated
Investigation typically begins with a detailed history of the lump—when it was first noticed, whether it has changed in size, and what injections the cat has received in recent months or years. Physical examination follows, assessing the mass for size, firmness, mobility, and whether it appears fixed to deeper structures. As the clinical picture sharpens, imaging and tissue sampling are used to characterise the mass more fully and guide decisions about management.
Physical examination
Fine-needle aspiration cytology
Incisional or excisional biopsy
Imaging (radiography or CT)
Blood tests
Options & trade-offs
Management of injection-site sarcomas is usually tailored to the individual cat, taking into account the tumour's size and location, the owner's resources and preferences, and the cat's overall health. Many approaches involve a combination of surgery, radiation, and sometimes chemotherapy, each contributing different effects. No single pathway suits every situation, and decisions often evolve as the response to initial treatment becomes clearer.
Aggressive surgical excision
Surgery aims to remove the tumour along with a wide margin of surrounding normal tissue—at least three centimetres, and preferably five centimetres, in all directions, including two fascial or muscle planes below the mass. This may involve removing muscle, fascia, or even portions of bone if the tumour is adherent. The intent is to reduce the chance of leaving microscopic disease behind, given the sarcoma's infiltrative growth pattern.
Trade-offs: Wide excision can be technically demanding and may result in large wounds that require reconstructive techniques or prolonged healing. Even with wide margins, recurrence at the same site occurs in a proportion of cases because microscopic projections can extend beyond what is visible or palpable. The practicality of this approach depends on tumour location; masses on the limbs or body wall may be more amenable to wide excision than those near the spine or neck.
Radiation therapy
Radiation is directed at the tumour bed either before surgery (to shrink the mass and make excision more feasible) or after surgery (to target any remaining microscopic disease). A course typically involves multiple sessions over several weeks, each requiring general anaesthesia or heavy sedation. Radiation can also be used alone in cases where surgery is not practical.
Trade-offs: Radiation requires access to a specialist facility and repeated anaesthetic episodes, which may not suit all cats or owners. Skin reactions, hair loss, and delayed wound healing can occur in the treatment field. Radiation does not guarantee that the tumour will not recur, but it can extend the time before regrowth becomes apparent.
Chemotherapy
Chemotherapy drugs are given systemically, either after surgery and radiation to address microscopic spread, or in cases where the tumour has already metastasised. The drugs used target rapidly dividing cells and are typically administered as a series of injections over several months.
Trade-offs: Chemotherapy is generally less effective against injection-site sarcomas than against some other tumour types, and its primary role is often to delay progression rather than achieve cure. Cats tend to tolerate chemotherapy better than dogs or humans, but side effects such as nausea, reduced appetite, and lowered white blood cell counts can occur and require monitoring.
Palliative or monitoring approach
In some cases—particularly when the tumour is small, slow-growing, or located in a site where aggressive treatment carries high morbidity—owners and vets may choose to monitor the mass over time, intervening only if it begins to cause discomfort or functional impairment. Pain relief, anti-inflammatory medication, or localised care may be used to maintain quality of life.
Trade-offs: This approach accepts that the tumour will likely continue to grow, and intervention becomes more complex as the mass enlarges. It can be a reasonable choice for older cats or those with concurrent illness, where the burden of treatment may outweigh the potential benefit. Regular reassessment is needed to detect changes in tumour behaviour or the cat's comfort.
Common misconceptions
"If the lump appeared months or years after a vaccine, it cannot be related to that injection."
The time between injection and tumour development is highly variable, with some masses appearing within weeks and others not becoming detectable for two or three years. The prolonged latency reflects the gradual accumulation of genetic changes in the affected cells, rather than an immediate transformation. A lump in a typical injection site warrants investigation regardless of how much time has passed since the last injection.
"Once a sarcoma has been surgically removed, the problem is resolved."
Injection-site sarcomas are characteristically infiltrative, often extending microscopic projections beyond the palpable edge of the tumour. Even with wide surgical margins, recurrence at the original site occurs in a substantial proportion of cases, sometimes months or years later. Ongoing monitoring and, in many cases, additional treatment such as radiation are part of the long-term management picture.
"All lumps at injection sites are sarcomas and need immediate aggressive treatment."
Many lumps that appear after an injection are benign inflammatory reactions or transient swellings that resolve within a few weeks. The concern arises when a lump persists beyond three months, continues to grow, or measures more than two centimetres in diameter. Investigation is used to distinguish between benign and malignant processes before deciding on a course of action.
Related conditions
Soft Tissue Sarcomas
Injection-site sarcomas in cats are a specific member of the soft tissue sarcoma family, sharing the same invasive growth pattern and irregular borders that make complete surgical removal challenging. The biological behaviour and treatment considerations overlap substantially, though injection-site sarcomas carry the additional context of a known trigger.
Fibrosarcoma in Dogs
Fibrosarcomas arise from the same fibroblast cell type that produces injection-site sarcomas in cats, and the two conditions share similar microscopic features and growth patterns. Understanding fibrosarcoma biology in dogs can inform how these connective tissue tumours behave across species.
Lipomas
Lipomas are benign fatty lumps that can appear in similar locations to injection-site sarcomas—under the skin along the back or flanks—and distinguishing between a soft, moveable lipoma and a firmer, more fixed mass is often an early step in evaluating any new lump in a cat.
Mast Cell Tumours in Cats
Mast cell tumours in cats can also present as skin lumps or nodules, and while their behaviour and underlying cell type differ from injection-site sarcomas, both conditions require biopsy to distinguish them from other masses and guide treatment decisions.
Sterile Nodular Panniculitis
Sterile nodular panniculitis produces firm lumps in the subcutaneous fat layer that can occasionally be mistaken for tumours, and because both conditions may appear at sites of prior inflammation or trauma, biopsy is often needed to differentiate inflammatory nodules from neoplastic growths.
Injection-site sarcomas sit within a broader landscape of tumour behaviour and tissue healing, and understanding how inflammation and tissue response interact can be useful context for other observations over time. The longevity and healthspan pillar explores related themes, including how aging tissues respond to injury and what factors influence wound healing and cellular resilience. For cats with confirmed sarcomas, conversations about tumour monitoring, pain recognition, and quality-of-life indicators can help shape ongoing care in a way that aligns with individual circumstances.